title: Is tranexamic acid really an alternative to aprotinin?
authors.forename: Gunther
authors.initials: G
authors.lastname: Wiesner
authors.forename: Peter
authors.initials: P
authors.lastname: Tassani
authors.forename: Christian
authors.initials: C
authors.lastname: Schreiber
authors.forename: Klaus
authors.initials: K
authors.lastname: Martin
mesh_terms: D000933:Antifibrinolytic Agents / Q000627:therapeutic use*; D007611:Aprotinin / Q000627:therapeutic use*; D016063:Blood Loss, Surgical; D006348:Cardiac Surgical Procedures; D005260:Female; D006330:Heart Defects, Congenital / Q000601:surgery*; D006801:Humans; D008297:Male; D014148:Tranexamic Acid / Q000627:therapeutic use*
chemical_list: D000933:Antifibrinolytic Agents; D014148:Tranexamic Acid; D007611:Aprotinin